Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 31 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

27Total
Not Applicable (21)
P 1 (2)
P 2 (3)
P 3 (1)

Trial Status

Not Yet Recruiting15
Completed8
Recruiting7
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 8 completed trials

Clinical Trials (31)

Showing 20 of 20 trials
NCT07853807Not ApplicableRecruitingPrimary

Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1

NCT07850102Phase 2Not Yet RecruitingPrimary

Brain Imaging of DSP-2342

NCT07820553Not Yet Recruiting

Building a Computational Model of Auditory Hallucinations

NCT07815587Not Yet Recruiting

Ultrasound Assessment of Gluteal Muscle in Patients Receiving Depot Antipsychotics and Healthy Volunteers

NCT07559084Not ApplicableNot Yet RecruitingPrimary

Multi-target TMS for Schizophrenia Negative Symptoms

NCT06817980Not ApplicableRecruitingPrimary

Disorders of the Sense of Self and Physical Activity

NCT07769749Not ApplicableNot Yet RecruitingPrimary

Basal Stimulation Therapy in Adults With Schizophrenia Requiring Institutional Care

NCT07759869Phase 3Not Yet RecruitingPrimary

A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia

NCT07757750Not ApplicableCompletedPrimary

Simulation-Based Schizophrenia Training in Nursing Education

NCT07748078Not ApplicableNot Yet RecruitingPrimary

Snoezelen Therapy in Adults With Alcohol Dependence and Adults With Schizophrenia

NCT07190352Not ApplicableCompletedPrimary

Behavioral Impact and Neural Correlates of Network-based Brain Stimulation in Schizophrenia

NCT07716969Recruiting

TOPUS - Testing an Implemented Intervention to Reduce Duration of Untreated Psychosis

NCT07423546Phase 1RecruitingPrimary

A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia

NCT07691190Phase 1CompletedPrimary

Bioequivalence Study to Compare Cariprazine 1.5 mg Hard Capsules (1.5 mg Cariprazine Hydrochloride) Versus Reagila® 1,5 mg Hartkapseln (Hard Capsules) (Cariprazine)

NCT07157293Not ApplicableNot Yet Recruiting

Online Intervention To Improve Motivation

NCT07661225Not ApplicableNot Yet RecruitingPrimary

The Effect of ACT-Based Nursing Interventions on Social Cognition, Emotion Regulation and Psychological Flexibility in Patients With Schizophrenia

NCT07656558Not ApplicableNot Yet RecruitingPrimary

ACT-Based Psychoeducation for Caregivers of Patients With Schizophrenia

NCT07427485Not ApplicableCompletedPrimary

Cognitive Rehabilitation With Immersive Virtual Reality (IVR) in Schizophrenia: a Pilot Randomized Waiting List Controlled Feasibility Study

NCT07632261Not ApplicableNot Yet RecruitingPrimary

Precision HD-tACS for Enhancing Sensory Experience in Schizophrenia

NCT07623928Not ApplicableNot Yet Recruiting

Developing a Virtual Reality-assisted Intervention for Emotion Regulation Difficulties in Psychosis

Scroll to load more

Research Network

Activity Timeline